logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Fulltext. Trends in cancer incidence and mortality in Vaud, Switzerland, 1974-1993.

    Article - En anglais

    Fulltext.

    Background 

    Comparing incidence of and mortality from cancer within a given population yields several benefits.

    One of these is the opportunity, when trends in incidence differ from those in mortality, to derive inferences about the potential role of improved diagnosis in the rise of incidence rates, and about therapeutic advancements in reducing mortality.

    Materials and methods 

    Trends in incidence of and mortality from various cancers or groups of cancers (comprising 55,682 new malignant tumours and 26,528 certified cancer deaths) over the period 1974-1993 were compared using, respectively, data from the Cancer Registry of the Swiss Canton of Vaud (with about 600,000 inhabitants) and those provided by the Swiss Federal Statistical Office.

    Results 

    The overall cancer incidence increased by 10% to 30% in both sexes and various age groups, whereas mortality remained approximately the same.

    The sites primarily responsible for these divergent trends were breast, prostate and colorectal, three sites where cancers have been less frequently diagnosed since the advent of certain technical advancements and the introduction of screening.

    Other contributors to the divergent trends were testicular cancer, Hodgkin's disease and leukaemias, i.e., the sites for which the most substantial therapeutic advancements have been achieved.

    Conclusions 

    These data are fairly reassuring, since they are inconsistent with an ongoing cancer epidemic in this European population. (...)

    Mots-clés Pascal : Tumeur maligne, Epidémiologie, Suisse, Europe, Incidence, Mortalité, Homme, Diagnostic

    Mots-clés Pascal anglais : Malignant tumor, Epidemiology, Switzerland, Europe, Incidence, Mortality, Human, Diagnosis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0378479

    Code Inist : 002B04B. Création : 10/04/1997.